[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medipharm Labs Corp (MEDIF)

Medipharm Labs Corp (MEDIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0500 +13.20%
on 08/25/26
0.0578 -2.08%
on 08/24/26
+0.0026 (+4.81%)
since 07/27/26
3-Month
0.0457 +23.85%
on 07/09/26
0.0646 -12.38%
on 06/17/26
-0.0017 (-2.92%)
since 05/27/26
52-Week
0.0415 +36.39%
on 11/28/25
0.0755 -25.03%
on 05/14/26
+0.0009 (+1.62%)
since 08/27/25

Most Recent Stories

More News
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA

Q2 2026 Adjusted EBITDA 1 of $0.9M, the Company’s strongest quarterly performance since 2019 2 Positive net income in Q2 2026, compared with a net loss of $3.8M in Q2 2025 OPEX decreased 44% in Q2...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA

MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results

MediPharm Labs is pleased to announce the company will release its 2026 second quarter financial results before markets open on Thursday, August 13 2026....

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results

TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp.  (TSX:  LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia

Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant improvements in agitation symptoms compared with...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia

Results presented by the LiBBY study team at the Alzheimer’s Association International Conference (“AAIC”) demonstrated statistically significant...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

MediPharm Labs announces the results of matters voted on at its annual and special meeting of shareholders held today. ...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders

TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting

Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time). The Board of Directors recommends shareholders vote FOR all director nominees and resolutions,...

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA

MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA....

MEDIF : 0.0566 (+0.71%)
LABS.TO : 0.0800 (unch)

Key Turning Points

3rd Resistance Point 0.0583
2nd Resistance Point 0.0575
1st Resistance Point 0.0570
Last Price 0.0566
1st Support Level 0.0557
2nd Support Level 0.0549
3rd Support Level 0.0544

See More

52-Week High 0.0755
Fibonacci 61.8% 0.0625
Fibonacci 50% 0.0585
Last Price 0.0566
Fibonacci 38.2% 0.0545
52-Week Low 0.0415

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.